Dr Craig Morton & Dr Tracy Nero - Bio21 Institute

Dr Craig Morton & Dr Tracy Nero - Bio21 Institute

Location: 
Online
Start Time: 
Mon 04/10/2021 - 11:00 AM
End Time: 
Wed 04/08/2021 - 11:30 AM

Online Postgraduate lecture – Drug Discovery Series hosted by Dr Jeff Mitchell
 
Dr Craig Morton
Senior Research Fellow, Dept of Biochemistry & Molecular Biology, School of Biomedical Sciences, Faculty of Medicine, Dentistry & Health Sciences, Bio21 Molecular Science & Biotechnology Institute, University of Melbourne
 
Dr Tracy Nero
Research Fellow, Structural Biology & Computational Design Laboratory, Dept of Biochemistry & Pharmacology,  Bio21 Molecular Science & Biotechnology Institute, University of Melbourne

 
Computer-Aided Drug Discovery - An Introduction
 

Watch the lecture recording, to be made available prior to the Q&A session
Join the live Q&A session via TEAMS

 
Dr Craig Morton is a Senior Research Fellow and Head of Computational Biology in the Computational Design Laboratory, Department of Biochemistry and Pharmacology at the University of Melbourne. Dr Morton has more than a decade’s experience in industry, as a principal research scientist and Head of Drug Target Discovery at the former Australian biotech company Biota. His expertise is in protein structure / function, protein – ligand interactions and computational small molecule drug discovery, with particular interest in anti-infective agents for the treatment of bacterial and viral diseases.
 
Dr Tracy Nero is a Research Fellow in the Structural Biology and Computational Design Laboratory, Department of Biochemistry and Pharmacology, The University of Melbourne located at the Bio21 Molecular Science and Biotechnology Institute in Melbourne, Australia. She completed her PhD in 1995. With a background in molecular modeling, structure-based drug design and structural bioinformatics, she has over 25 years research experience in both the Australian biotechnology industry and academic research. Her research explores the structure and function of therapeutic protein targets and the discovery of small molecules acting on these proteins. Dr Nero’s published work broadly covers the therapeutic areas of cancer, infection and neurodegeneration. She has a particular interest in the structure and function of the β-common family of cytokines, GM-CSF, IL-3 and IL-5.
 
All welcome!